Nephros Inc. (NEPH) vs Regentis Biomaterials Ltd. (RGNT)

Nephros Inc. and Regentis Biomaterials Ltd. are both Medical Instruments & Supplies companies. Nephros Inc. is the larger, with a market value of $45.0M against $15.8M — 2.8× the size. Across the 8 metrics below, Nephros Inc. leads on 5 and Regentis Biomaterials Ltd. on 3.

Valuation

Metric NEPH RGNT Medical Instruments & Supplies median
P/E 27.15 — 34.17
P/S 2.22 — 2.83
P/B 3.84 n/m 2.82
Price to free cash flow n/m n/m 25.69
EV/EBITDA 23.83 n/m 16.08
EV/Sales 2.03 n/m 3.06
Earnings yield 3.68% — (1.84%)
Free cash flow yield (1.71%) 0.00% 0.17%

Profitability

Metric NEPH RGNT Medical Instruments & Supplies median
Gross margin 61.26% — 54.62%
Operating margin 7.92% — 1.64%
Net margin 8.38% — 0.00%
Free cash flow margin (3.19%) 0.00% 1.61%
Return on equity 16.10% 0.00% 0.00%
Return on assets 12.39% 0.00% 0.00%
Return on invested capital 14.11% 0.00% 0.00%

Growth

Metric NEPH RGNT Medical Instruments & Supplies median
Revenue growth (TTM) 24.20% — 9.20%
EPS growth (last fiscal year) 1,471.43% (1,504.65%) —
Revenue growth, 5-year CAGR 17.02% — 9.48%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric NEPH RGNT Medical Instruments & Supplies median
Debt to equity 0.00 0.00 0.08
Current ratio 4.07 5.62 2.49
Net debt to EBITDA (4.20) 0.89 0.83

Dividend

Metric NEPH RGNT Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio 0.00 — 0.00

Size

Metric NEPH RGNT Medical Instruments & Supplies median
Market cap 44.96m 15.82m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack